Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing <i>Klebsiella pneumoniae</i>

Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing <i>Klebsiella pneumoniae</i>

The aim of this study was to compare the reference broth microdilution (BMD) method with the Disk Diffusion (DD) test and strip test against a collection of 75 well-characterized <i>Klebsiella pneumoniae</i> carbapenemase (KPC)-producing <i>Klebsiella pneumoniae</i> (KPC-Kp)...

Full description

Bibliographic Details
Main Authors:	Federica Bovo, Tiziana Lazzarotto, Simone Ambretti, Paolo Gaibani
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Antibiotics
Subjects:	cefiderocol antimicrobial susceptibility testing (AST) antimicrobial resistance (AMR) <i>Klebsiella pneumoniae</i> carbapenemase
Online Access:	https://www.mdpi.com/2079-6382/12/3/614

Similar Items

Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in <i>Acinetobacter baumannii</i>
by: Natalia Kolesnik-Goldmann, et al.
Published: (2023-07-01)

Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria
by: Marta Palombo, et al.
Published: (2023-05-01)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
by: Stefano Stracquadanio, et al.
Published: (2022-10-01)

Performance of the Disc Diffusion Method, MTS Gradient Tests and Two Commercially Available Microdilution Tests for the Determination of Cefiderocol Susceptibility in <i>Acinetobacter</i> spp.
by: Katy Jeannot, et al.
Published: (2023-07-01)

Electrochemical detection of cefiderocol for therapeutic drug monitoring
by: James McLeod, et al.
Published: (2021-12-01)

Analysis of In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Gram-Negative Bacilli by Broth Microdilution and Disk Diffusion Method: A Single-Center Study in Odisha, India
by: Nayak G, et al.
Published: (2022-10-01)

Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against Acinetobacter baumannii complex clinical isolates
by: Yanling Liu, et al.
Published: (2023-12-01)

Disc Diffusion and ComASP<sup>®</sup> Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine
by: Gabriele Bianco, et al.
Published: (2023-03-01)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023-12-01)

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against <i>Acinetobacter baumannii</i> Strains Recovered from Clinical Samples
by: Davide Carcione, et al.
Published: (2021-10-01)

Reduce susceptibility to cefiderocol in gram negative bacteria in children: Is hope already lost before it’s even arrived?
by: Chiara Russo, et al.
Published: (2024-04-01)

In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii clinical isolates: a single center experience.
by: Giovanni Matera
Published: (2023-06-01)

An Overview of Cefiderocol’s Therapeutic Potential and Underlying Resistance Mechanisms
by: Sara Domingues, et al.
Published: (2023-06-01)

In-Vitro Efficacy of Cefiderocol in Carbapenem-Non-Susceptible Gram-Negative Bacilli of Different Genotypes in Sub-Region of North Rhine Westphalia, Germany
by: Beniam Ghebremedhin, et al.
Published: (2021-09-01)

Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9
by: Susie Gaillot, et al.
Published: (2023-08-01)

Cefiderocol against Multi-Drug and Extensively Drug-Resistant <i>Escherichia coli</i>: An In Vitro Study in Poland
by: Patrycja Zalas-Więcek, et al.
Published: (2022-12-01)

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data
by: Giacobbe DR, et al.
Published: (2020-12-01)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
by: Keith S. Kaye, et al.
Published: (2023-02-01)

Cefiderocol for Severe Carbapenem-Resistant <i>A. baumannii</i> Pneumonia: Towards the Comprehension of Its Place in Therapy
by: Emanuele Rando, et al.
Published: (2021-12-01)

Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study
by: Alexandre Bleibtreu, et al.
Published: (2021-01-01)

In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in Italy
by: Stefano Stracquadanio, et al.
Published: (2021-06-01)

Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations
by: Andrea Marino, et al.
Published: (2022-12-01)

Broth Microdilution and Gradient Diffusion Strips vs. Reference Agar Dilution Method: First Evaluation for <i>Clostridiales</i> Species Antimicrobial Susceptibility Testing
by: Florian Baquer, et al.
Published: (2021-08-01)

Concordance of disk diffusion, broth microdilution, and whole‐genome sequencing for determination of in vitro antimicrobial susceptibility of Mannheimia haemolytica
by: Emily R. Snyder, et al.
Published: (2020-09-01)

Antimicrobial susceptibility testing by broth microdilution method: widely available modification
by: Tapalskiy D.V., et al.
Published: (2018-02-01)

Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa
by: María Fernanda Mojica, et al.
Published: (2020-06-01)

Comparative Evaluation of Vitek 2 and Etest versus Broth Microdilution for Ceftazidime/Avibactam and Ceftolozane/Tazobactam Susceptibility Testing of <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>
by: Arhodoula Papadomanolaki, et al.
Published: (2022-06-01)

Occurrence, resistance patterns, and management of carbapenemase-producing bacteria in war-wounded refugees from Ukraine
by: Fabian K. Berger, et al.
Published: (2023-07-01)

Human Serum Proteins and Susceptibility of <i>Acinetobacter baumannii</i> to Cefiderocol: Role of Iron Transport
by: Casin Le, et al.
Published: (2022-03-01)

Differences in the Propensity of Different Antimicrobial Resistance Determinants to Be Disseminated via Transformation in <i>Campylobacter jejuni</i> and <i>Campylobacter coli</i>
by: Zahra Hanafy, et al.
Published: (2022-06-01)

In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014−2018 studies in Spain
by: Emilia Cercenado, et al.
Published: (2021-09-01)

Towards a Standardized Antimicrobial Susceptibility Testing Method for <i>Mycoplasma hyorhinis</i>
by: Lisa Käbisch, et al.
Published: (2023-04-01)

Comparative Evaluation of VITEK 2 and Broth Microdilution Methods for Colistin Antimicrobial Susceptibility Test
by: Birol ŞAFAK, et al.
Published: (2020-04-01)

Comprehensive Statistical Evaluation of Etest<sup>®</sup>, UMIC<sup>®</sup>, MicroScan and Disc Diffusion versus Standard Broth Microdilution: Workflow for an Accurate Detection of Colistin-Resistant and <i>Mcr</i>-Positive <i>E. coli</i>
by: Isidro García-Meniño, et al.
Published: (2020-12-01)

Evaluation of a Method for Standardized Antimicrobial Susceptibility Testing with <i>Mycoplasma hyorhinis</i> Field Isolates
by: Lisa Käbisch, et al.
Published: (2023-11-01)

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of <i>Acinetobacter baumannii</i> Clinical Isolates
by: Clara Ballesté-Delpierre, et al.
Published: (2022-01-01)

First Finding of a Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) t304/ST6 from Bovine Clinical Mastitis
by: Desiree Corvera Kløve, et al.
Published: (2022-10-01)

Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance
by: Stamatis Karakonstantis, et al.
Published: (2022-05-01)

Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
by: Davide Fiore Bavaro, et al.
Published: (2021-05-01)

Provisional Use of CLSI-Approved Quality Control Strains for Antimicrobial Susceptibility Testing of <i>Mycoplasma</i> (<i>‘Mesomycoplasma’</i>) <i>hyorhinis</i>
by: Lisa Käbisch, et al.
Published: (2021-08-01)